KannaLife Sciences was mentioned in an article by Vice written by Payton Guion about the NFL’s drug policy and how their CBD based products could help prevent brain damage.
“KannaLife, a New York-based company, is now working with the federal government to develop a drug that may prevent certain neurological disorders, including CTE. But the drug is derived from marijuana, which has made the NFL reluctant to lend its support.”
